Corneal cross-linking is an in-office procedure that works to strengthen and stabilize the cornea in eyes that have weakness from keratoconus or ectasia. At Baylor Medicine, our cornea specialists are ...
A PDUFA date has been set for October 20, 2025. If approved, Epoxia will be the first epi-on corneal crosslinking on the ...
Becoming the second institution after GMC Srinagar, SKIMS Medical College & Hospital (MCH), Bemina, is set to begin corneal ...
10monon MSN
The resulting free radicals then ensure that additional cross-linking occurs within the collagen fibers of the cornea, making ...
Hosted on MSN10d
Mizuho Upgrades Glaukos (GKOS)Fintel reports that on February 19, 2025, Mizuho upgraded their outlook for Glaukos (NYSE:GKOS) from Neutral to Outperform.
Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its ...
stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions. Glaukos is leveraging its platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback